These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 34248856)

  • 1. Non-invasive Beta-cell Imaging: Visualization, Quantification, and Beyond.
    Murakami T; Fujimoto H; Inagaki N
    Front Endocrinol (Lausanne); 2021; 12():714348. PubMed ID: 34248856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Specific Activity by Multichelation of Exendin-3 Leads To Improved Image Quality and In Vivo Beta Cell Imaging.
    Joosten L; Brom M; Peeters H; Heskamp S; Béhé M; Boerman O; Gotthardt M
    Mol Pharm; 2018 Feb; 15(2):486-494. PubMed ID: 29226686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of an
    Kimura H; Fujita N; Kanbe K; Matsuda H; Watanabe H; Arimitsu K; Fujimoto H; Hamamatsu K; Yagi Y; Ono M; Inagaki N; Saji H
    Bioorg Med Chem; 2017 Oct; 25(20):5772-5778. PubMed ID: 28927802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive quantification of the beta cell mass by SPECT with ¹¹¹In-labelled exendin.
    Brom M; Woliner-van der Weg W; Joosten L; Frielink C; Bouckenooghe T; Rijken P; Andralojc K; Göke BJ; de Jong M; Eizirik DL; Béhé M; Lahoutte T; Oyen WJ; Tack CJ; Janssen M; Boerman OC; Gotthardt M
    Diabetologia; 2014 May; 57(5):950-9. PubMed ID: 24488022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring the Pancreatic β Cell Mass in Vivo with Exendin SPECT during Hyperglycemia and Severe Insulitis.
    Joosten L; Brom M; Peeters H; Bos D; Himpe E; Bouwens L; Boerman O; Gotthardt M
    Mol Pharm; 2019 Sep; 16(9):4024-4030. PubMed ID: 31345042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive Evaluation of GPR119 Agonist Effects on β-Cell Mass in Diabetic Male Mice Using 111In-Exendin-4 SPECT/CT.
    Murakami T; Fujimoto H; Fujita N; Hamamatsu K; Matsumoto K; Inagaki N
    Endocrinology; 2019 Dec; 160(12):2959-2968. PubMed ID: 31613319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive Evaluation of GIP Effects on β-Cell Mass Under High-Fat Diet.
    Kiyobayashi S; Murakami T; Harada N; Fujimoto H; Murata Y; Fujita N; Hamamatsu K; Ikeguchi-Ogura E; Hatoko T; Lu X; Yamane S; Inagaki N
    Front Endocrinol (Lausanne); 2022; 13():921125. PubMed ID: 35909510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preservation effect of imeglimin on pancreatic β-cell mass: Noninvasive evaluation using
    Fauzi M; Murakami T; Fujimoto H; Botagarova A; Sakaki K; Kiyobayashi S; Ogura M; Inagaki N
    Front Endocrinol (Lausanne); 2022; 13():1010825. PubMed ID: 36246910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive longitudinal quantification of β-cell mass with [
    Fujita N; Fujimoto H; Hamamatsu K; Murakami T; Kimura H; Toyoda K; Saji H; Inagaki N
    FASEB J; 2019 Nov; 33(11):11836-11844. PubMed ID: 31370679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the preservation effect of canagliflozin on pancreatic beta cell mass using SPECT/CT imaging with
    Hamamatsu K; Fujimoto H; Fujita N; Murakami T; Shiotani M; Toyoda K; Inagaki N
    Sci Rep; 2019 Dec; 9(1):18338. PubMed ID: 31797889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-Glycine as a marker for β cell imaging and β cell mass evaluation.
    Han Y; Liu H; Li Y; Liu Z
    Eur J Nucl Med Mol Imaging; 2024 Jul; 51(9):2558-2568. PubMed ID: 38632133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive glucagon-like peptide-1 receptor imaging in pancreas with (18)F-Al labeled Cys(39)-exendin-4.
    Mi B; Xu Y; Pan D; Wang L; Yang R; Yu C; Wan W; Wu Y; Yang M
    Biochem Biophys Res Commun; 2016 Feb; 471(1):47-51. PubMed ID: 26850848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of
    Kimura H; Matsuda H; Ogawa Y; Fujimoto H; Toyoda K; Fujita N; Arimitsu K; Hamamatsu K; Yagi Y; Ono M; Inagaki N; Saji H
    Bioorg Med Chem; 2017 Feb; 25(4):1406-1412. PubMed ID: 28089587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of
    Kimura H; Ogawa Y; Fujimoto H; Mukai E; Kawashima H; Arimitsu K; Toyoda K; Fujita N; Yagi Y; Hamamatsu K; Murakami T; Murakami A; Ono M; Nakamoto Y; Togashi K; Inagaki N; Saji H
    Bioorg Med Chem; 2018 Jan; 26(2):463-469. PubMed ID: 29273416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive quantitative evaluation of viable islet grafts using
    Botagarova A; Murakami T; Fujimoto H; Fauzi M; Kiyobayashi S; Otani D; Fujimoto N; Inagaki N
    FASEB J; 2023 Apr; 37(4):e22859. PubMed ID: 36906290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Cu-64 and Ga-68 Radiolabeled Glucagon-Like Peptide-1 Receptor Agonists as PET Tracers for Pancreatic β cell Imaging.
    Bandara N; Zheleznyak A; Cherukuri K; Griffith DA; Limberakis C; Tess DA; Jianqing C; Waterhouse R; Lapi SE
    Mol Imaging Biol; 2016 Feb; 18(1):90-8. PubMed ID: 25987465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive in vivo determination of viable islet graft volume by
    Eter WA; Van der Kroon I; Andralojc K; Buitinga M; Willekens SMA; Frielink C; Bos D; Joosten L; Boerman OC; Brom M; Gotthardt M
    Sci Rep; 2017 Aug; 7(1):7232. PubMed ID: 28775287
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.